Judge blocks part of Idaho’s new abortion law in first post-Roe lawsuit by the Biden administration

Judge blocks part of Idaho’s new abortion law in first post-Roe lawsuit by the Biden administration


A protest taking place after Planned Parenthood affiliate filed a lawsuit in the Idaho Supreme Court to stop the state to trigger a law that effectively bans abortion. A federal judge on Wednesday temporarily blocked part of Idaho’s strict abortion law that’s scheduled to take effect Thursday, handing the Biden administration a narrow courtroom win in its first lawsuit to protect reproductive rights since the Supreme Court overturned Roe v. Wade.

Idaho Statesman | Tribune News Service | Getty Images

A federal judge on Wednesday temporarily blocked part of Idaho’s strict abortion law that’s scheduled to take effect Thursday, handing the Biden administration a narrow courtroom win in its first lawsuit to protect reproductive rights since the Supreme Court overturned Roe v. Wade.

The ruling from Judge B. Lynn Winmill prevents Idaho from enforcing the new law when it conflicts with federal guidance on emergency abortion care in hospitals.

“The State of Idaho will not suffer any real harm if the Court issues the modest preliminary injunction the United States is requesting,” Winmill wrote.

U.S. Attorney General Merrick Garland announced the lawsuit against Idaho earlier this month, and argued that the state’s law conflicted with a federal statute known as the Emergency Medical Treatment and Labor Act, or EMTALA, which was enacted in 1986 to ensure patients receive adequate emergency medical care.

That law requires doctors to provide the emergency medical treatment necessary to stabilize anyone who comes into an emergency room. “This includes abortion, when that is the necessary treatment,” Garland said at the time.

Winmill heard arguments on the Justice Department’s request for a preliminary injunction Monday and said he would issue a written order no later than Wednesday. The state law is still scheduled to take effect Thursday, minus the provision Winmill said the state cannot enforce for now.

While the state argued that its law did not conflict with EMTALA, Winmill found its argument was not persuasive, “because it has failed to properly account for the staggeringly broad scope of its law,” which he said “criminalizes all abortions.”

“It is impossible to comply with both statutes,” Winmill wrote. “[W]here federal law requires the provision of care and state law criminalizes that very care, it is impossible to comply with both laws. Full stop.”



Source

Trump reaches deal with AstraZeneca to lower U.S. drug prices, MSNBC reports
Health

Trump reaches deal with AstraZeneca to lower U.S. drug prices, MSNBC reports

U.S. President Donald Trump participates in a bilateral meeting with Finland’s President Alexander Stubb (not pictured), in the Oval office at the White House in Washington, D.C., U.S., Oct. 9, 2025. Nathan Howard | Reuters The Trump administration and AstraZeneca have reached an agreement for the U.K.-based pharmaceutical giant to cut drug prices in the […]

Read More
At-risk teens and AI chatbot crisis: ‘You need to know what’s going on,’ warns Talkspace CEO
Health

At-risk teens and AI chatbot crisis: ‘You need to know what’s going on,’ warns Talkspace CEO

Talkspace has grown to be one of the largest online therapy platforms in the U.S., covering an estimated market of 200 million Americans. As the mental health platform has grown, it has also pioneered new ways to reach people in need of help with mental health issues including trauma, depression, addiction, abuse and relationships, and […]

Read More
Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers
Health

Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers

The Amgen headquarters in Thousand Oaks, California. Eric Thayer | Bloomberg | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Drugmakers are increasingly using telehealth platforms to sell their medicines directly to patients […]

Read More